British Society for Rheumatology > Knowledge > Registers

Registers

Knowledge * Registers

The society runs four biologics and biosimilars registers. Three are for adult patients receiving treatments for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, and the fourth is for young patients with juvenile idiopathic arthritis. The data collected from these registers generates vital evidence on patient safety in the long term as well as the efficacy of treatment.

We are keen to promote the use of data from the registers by other researchers who are not part of the core academic teams. You can apply for access to some of the data to enable important additional research and analysis by clicking here.

To access published papers relating to the registers, please click here 

Our four registers:

Rheumatoid arthritis register

5 new drugs being recruited for

This register is run by an expert team based in the Arthritis Research UK Epidemiology Unit at the University of Manchester.

Find out more

Ankylosing spondylitis register

This register has now stopped recruiting but you can still access data from it for your own research. Find out more at the bottom of this page.

Find out more

Psoriatic Arthritis register

We are pleased to announce the launch of the Psoriatic Arthritis register. Preparatory work for this register is underway and recruitment will open in Autumn 2018.

Find out more

Juvenile idiopathic arthritis register

This register collects detailed information on the effectiveness and safety of treatments for children with juvenile idiopathic arthritis.

Find out more

Latest Tweet

@RheumatologyUK

New to #Twitter or want to meet fellow #tweeters? Join the official #Rheum2017 tweetup, BSR stand, 08:30, 25 Apr, exhibition hall

Contact us

British Society for Rheumatology
Bride House, 18-20 Bride Lane,
London EC4Y 8EE
T: +44 (0) 20 7842 0900
E: bsr@rheumatology.org.uk
Company No: 3470316
Charity No: 1067124
VAT No: 404 5637 66

Join us

We are the UK's leading specialist medical society for rheumatology and musculoskeletal professionals, and we welcome applications from all health professionals in these fields.